STX7 promotes EMT and tumor progression via NF-κB signaling, with a strong association to macrophage infiltration in cancers, including hepatocellular carcinoma, highlighting its potential as a prognostic biomarker and therapeutic target. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.